- Home
- RGT vs ME Comparison
RGT vs ME Comparison
Compare RGT & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGT
- ME
- Stock Information
- Founded
- RGT 1986
- ME 2006
- Country
- RGT United States
- ME United States
- Employees
- RGT N/A
- ME N/A
- Industry
- RGT Trusts Except Educational Religious and Charitable
- ME Precision Instruments
- Sector
- RGT Finance
- ME Health Care
- Exchange
- RGT Nasdaq
- ME Nasdaq
- Market Cap
- RGT 67.6M
- ME 68.4M
- IPO Year
- RGT N/A
- ME N/A
- Fundamental
- Price
- RGT $11.18
- ME $2.42
- Analyst Decision
- RGT
- ME Hold
- Analyst Count
- RGT 0
- ME 1
- Target Price
- RGT N/A
- ME $9.40
- AVG Volume (30 Days)
- RGT 22.4K
- ME 235.7K
- Earning Date
- RGT 01-01-0001
- ME 01-28-2025
- Dividend Yield
- RGT 1.43%
- ME N/A
- EPS Growth
- RGT N/A
- ME N/A
- EPS
- RGT 0.92
- ME N/A
- Revenue
- RGT N/A
- ME $208,775,000.00
- Revenue This Year
- RGT N/A
- ME $22.00
- Revenue Next Year
- RGT N/A
- ME $17.31
- P/E Ratio
- RGT $11.42
- ME N/A
- Revenue Growth
- RGT N/A
- ME N/A
- 52 Week Low
- RGT $7.84
- ME $2.42
- 52 Week High
- RGT $11.08
- ME $13.74
- Technical
- Relative Strength Index (RSI)
- RGT 54.57
- ME 32.49
- Support Level
- RGT $11.19
- ME $2.42
- Resistance Level
- RGT $11.29
- ME $2.96
- Average True Range (ATR)
- RGT 0.12
- ME 0.19
- MACD
- RGT 0.01
- ME 0.01
- Stochastic Oscillator
- RGT 76.56
- ME 0.00
About RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.